Florida Hospital, part of Adventist Health System, will soon begin using ePRISM®, a technology platform from Health Outcomes Sciences (HOS) that automates calculations of risk and appropriate use for individual patients receiving angioplasty.
ePRISM software digitizes and makes accessible research data that previously may have sat unused for years. Using this assembled data, ePRISM will bring predictive risk modeling into the workflow, allowing clinical teams the opportunity to better understand the specific risks of individual patients, and will assist the physicians in making more informed and confident clinical decisions.
"Florida Hospital is always looking for new technologies that will allow us to provide exceptional care to our patients," said Kimberly Bell, assistant vice president of the Florida Hospital Cardiovascular Institute. "By working with the team from Health Outcomes Sciences and their ePRISM platform, we will be able to deliver precision medicine at the bedside."
ePRISM will allow Florida Hospital clinicians to gauge patients' risk for PCI bleeding, acute kidney injuring, restenosis and mortality, and to decide appropriate use of coronary revascularization, prior to the start of the procedure.
Florida Hospital will serve as a reference site for Health Outcomes Sciences and will also help develop new models of care delivery in cardiology. Specific areas of focus include interventional cardiology, cardiothoracic surgery and electrophysiology.
ePRISM will first be deployed at Florida Hospital Celebration Health, and will then be put into use at Florida Hospital locations across Central Florida over the next year.
